Cargando…
Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
Autores principales: | Lian, Jingxuan, Fu, Jianfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889626/ https://www.ncbi.nlm.nih.gov/pubmed/35250889 http://dx.doi.org/10.3389/fendo.2022.840299 |
Ejemplares similares
-
Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021) -
Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021) -
Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023) -
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021) -
Alterations in Mitochondrial Oxidative Stress and Mitophagy in Subjects with Prediabetes and Type 2 Diabetes Mellitus
por: Bhansali, Shipra, et al.
Publicado: (2017)